June 1 (Reuters) - Integral Diagnostics Ltd (IDX) :
- REAFFIRMS IT WILL ACHIEVE NORMALISED FY18 NPAT GROWTH OF AROUND 20 PERCENT
- REAFFIRMS EBITDA GUIDANCE FOR FY18 OF $38 MILLION TO $39 MILLION
- BUYS GEELONG MEDICAL IMAGING; PURCHASE PRICE $4.7 MILLION ON A CASH AND DEBT FREE BASIS
June 1 (Reuters) - Integral Diagnostics Ltd (IDX) : REAFFIRMS...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.90 |
Change
0.050(1.75%) |
Mkt cap ! $1.080B | |||
| Open | High | Low | Value | Volume |
| $2.90 | $2.90 | $2.84 | $1.884M | 653.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1748 | $2.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.99 | 25400 | 2 |
View Market Depth
| Last trade - 16.10pm 05/09/2025 (20 minute delay) ? |
| IDX (ASX) Chart |